GSK’s ViiV Healthcare and its bimonthly pre-exposure prophylaxis (PrEP) medicine Apretude had to make room for another ...
The role puts Trépanier at the helm of Publicis Health Media’s (PHM’s) healthcare professional-focused practice and tasks him ...
With sales of potential blockbuster Lokelma scaling up, AstraZeneca is bolstering its production of the hyperkalemia ...
Codis, born from the fusion of U.S.-based Particle Dynamics and a U.K. | In addition to substantial spray drying capacity, ...
Sometimes, an agency’s staffing needs can lead to the discovery of a new passion. | In a Q&A for Fierce Pharma Marketing’s ...
Brexafemme (ibrexafungerp) partners GSK and Scynexis have worked out their quarrel related to a clinical trial that was previously put on hold, leaving Scynexis with a $22 million payout. | Through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback